January 29, 2015 1:53 PM ET


Company Overview of Aspreva International Ltd.

Company Overview

Aspreva International Ltd. identifies, develops, and commercializes approved drugs and drug candidates for new indications. It has two phase III clinical development programs underway to evaluate CellCept, an orally delivered immunosuppressant agent, in the treatment of the autoimmune diseases, such as lupus nephritis and pemphigus vulgaris. The company operates in the United States, Canada, Switzerland, and the United Kingdom. Aspreva International Ltd. was formerly known as Aspreva Pharmaceuticals Corporation and changed its name to Aspreva International Ltd. in May 2009. The company was founded in 2001 and is based in Victoria, Canada. Aspreva International Ltd. operates as a subsidiary o...

4464 Markham Street

Suite 1203

Victoria, BC V8Z 7X8


Founded in 2001

95 Employees





Key Executives for Aspreva International Ltd.

President and Director
Age: 65
Age: 52
Co-Founder and Chief Medical Advisor
Age: 62
Corporate Compliance Officer
Age: 49
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Omega Laboratories Limited Americas
Viropro International, Inc. Americas
Cadherin Biomedical Inc. Americas
Viventia Biotechnologies Inc. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aspreva International Ltd., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.